206 related articles for article (PubMed ID: 8326764)
1. Radiobiological assessment of non-standard and novel radiotherapy treatments using the linear-quadratic model.
Dale RG
Med Biol Eng Comput; 1993 Jan; 31(1):53-7. PubMed ID: 8326764
[TBL] [Abstract][Full Text] [Related]
2. Spinal cord response to altered fractionation and re-irradiation: radiobiological considerations and role of bioeffect models.
Supe SS; Ganesh KM; Naveen T; Jacob S; Sankar BN
J Cancer Res Ther; 2006; 2(3):105-18. PubMed ID: 17998688
[TBL] [Abstract][Full Text] [Related]
3. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
4. The evolution of practical radiobiological modelling.
Jones B; Dale RG
Br J Radiol; 2019 Jan; 92(1093):20180097. PubMed ID: 29557215
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
[TBL] [Abstract][Full Text] [Related]
6. Derivation of the optimum dose per fraction from the linear quadratic model.
Jones B; Tan LT; Dale RG
Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
[TBL] [Abstract][Full Text] [Related]
7. The radiobiology of conventional radiotherapy and its application to radionuclide therapy.
Dale R; Carabe-Fernandez A
Cancer Biother Radiopharm; 2005 Feb; 20(1):47-51. PubMed ID: 15778580
[TBL] [Abstract][Full Text] [Related]
8. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
[TBL] [Abstract][Full Text] [Related]
9. A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy.
Dale RG
Br J Radiol; 1986 Nov; 59(707):1111-5. PubMed ID: 3790899
[TBL] [Abstract][Full Text] [Related]
10. Application of the linear-quadratic-concept for prediction of late complications after combined irradiation of the uterine cervix.
Visser PA; Moonen LM; van der Kogel AJ; Keijser AH
Radiother Oncol; 1985; 4(2):133-41. PubMed ID: 4070679
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.
Dale RG
Radiother Oncol; 1989 Aug; 15(4):371-81. PubMed ID: 2798939
[TBL] [Abstract][Full Text] [Related]
12. Isoeffect relationships for fractionated biologically targeted radiotherapy.
O'Donoghue JA
Radiother Oncol; 1990 Nov; 19(3):257-65. PubMed ID: 2281155
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
Armpilia C; Dale RG; Sandilos P; Vlachos L
Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
[TBL] [Abstract][Full Text] [Related]
14. Mathematical models of tumour and normal tissue response.
Jones B; Dale RG
Acta Oncol; 1999; 38(7):883-93. PubMed ID: 10606418
[TBL] [Abstract][Full Text] [Related]
15. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
Scheidegger S; Lutters G; Bodis S
Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
[TBL] [Abstract][Full Text] [Related]
16. [Construction of radiobiological models as TCP (tumor control probability) and NTCP (normal tissue complication probability): from dose to clinical effects prediction].
Chaikh A; Thariat J; Thureau S; Tessonnier T; Kammerer E; Fontbonne C; Dubray B; Balosso J; Fontbonne JM
Cancer Radiother; 2020 Jun; 24(3):247-257. PubMed ID: 32220563
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
18. The 1989 James Kirk memorial lecture. The potential for radiobiological modelling in radiotherapy treatment design.
Dale RG
Radiother Oncol; 1990 Nov; 19(3):245-55. PubMed ID: 2281154
[TBL] [Abstract][Full Text] [Related]
19. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
[TBL] [Abstract][Full Text] [Related]
20. The radiobiology of targeted radiotherapy.
Wheldon TE; O'Donoghue JA
Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
